BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 8930195)

  • 21. Myocardial salvage by a novel thromboxane A2 synthetase inhibitor in a canine coronary occlusion-reperfusion model.
    Toki Y; Hieda N; Okumura K; Hashimoto H; Ito T; Ogawa K; Satake T
    Arzneimittelforschung; 1988 Feb; 38(2):224-7. PubMed ID: 3370068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent.
    Aisaka K; Hidaka T; Inomata N; Hamasaki S; Ishihara T; Morita M
    Arzneimittelforschung; 1985; 35(8):1239-45. PubMed ID: 4074441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of a thrombin inhibitor and a platelet GP IIb/IIIa antagonist in vivo: evidence that thrombin mediates platelet aggregation and subsequent thromboxane A2 formation during coronary thrombolysis.
    Pratico D; Murphy NP; Fitzgerald DJ
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1178-85. PubMed ID: 9190851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic effect of acute oxygen-ozone administration to rats.
    Di Filippo C; Cervone C; Rossi C; di Ronza C; Marfella R; Capodanno P; Luongo C; Rossi F; D'Amico M
    Eur J Pharmacol; 2010 Mar; 629(1-3):89-95. PubMed ID: 19958767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Beneficial effect of a stable PGI2 analogue (ONO-1301) on prostanoid release after reperfusion in canine left single lung allotransplantation model].
    Minamoto K
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Dec; 45(12):1931-42. PubMed ID: 9455104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of antiarrhythmic drugs to affect epicardial delay during acute experimental coronary artery occlusion and reperfusion: correlation with lack of antiarrhythmic efficacy.
    Naito M; Michelson EL; Kmetzo JJ; Kaplinsky E; Dreifus LS
    J Pharmacol Exp Ther; 1981 Aug; 218(2):475-80. PubMed ID: 7252847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antiplatelet profiles of the new thromboxane synthetase inhibitor sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo[b]thiophene-6-carboxylate.
    Asai F; Ito T; Ushiyama S; Matsuda K; Oshima T
    Arzneimittelforschung; 1991 May; 41(5):506-10. PubMed ID: 1898421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a thromboxane A2 synthetase inhibitor on ventricular fibrillation threshold during coronary artery occlusion and reperfusion.
    Toda I; Nozaki A; Kawakubo K; Murakawa Y; Inoue H; Yoshimoto N; Sugimoto T
    Jpn Heart J; 1990 Jan; 31(1):87-97. PubMed ID: 2335849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of bidisomide (SC-40230), a new class I antiarrhythmic agent, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats; comparison with mexiletine and disopyramide.
    Komori S; Sano S; Li BH; Matsumura K; Naitoh A; Mochizuki S; Ishihara T; Watanabe A; Umetani K; Ijiri H
    Heart Vessels; 1995; 10(1):7-11. PubMed ID: 7537263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of almokalant a specific inhibitor of IKr on myocardial ischaemia-reperfusion induced arrhythmias in rabbits.
    Farkas A; Leprán I; Papp JG
    Acta Physiol Hung; 1996; 84(3):281-2. PubMed ID: 9219607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cicletanine and reperfusion injury: is there any correlation between arrhythmias, 6-keto-PGF1 alpha, thromboxane B2, and myocardial ion shifts (Na+, K+, Ca2+, and Mg2+) induced by ischemia/reperfusion in isolated rat heart.
    Tosaki A; Hellegouarch A; Braquet P
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):551-9. PubMed ID: 1711620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of mexiletine on reperfusion-induced ventricular arrhythmias: comparison with lidocaine.
    Bonaduce D; Ferrara N; Abete P; Longobardi G; Leosco D; Canonico V; Morgano G; Rengo F
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):19-29. PubMed ID: 3827408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cicletanine on reperfusion-induced arrhythmias and its relation to 6-keto-PGF1 alpha and thromboxane B2 release.
    Tosaki A; Viossat I; Braquet P
    Can J Physiol Pharmacol; 1991 Apr; 69(4):488-93. PubMed ID: 2059911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
    Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
    Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmic effect of caffeic acid phenethyl ester (CAPE) on myocardial ischemia/reperfusion injury in rats.
    Huang SS; Liu SM; Lin SM; Liao PH; Lin RH; Chen YC; Chih CL; Tsai SK
    Clin Biochem; 2005 Oct; 38(10):943-7. PubMed ID: 16098504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stretch-induced contraction of rabbit isolated pulmonary artery and the involvement of endothelium-derived thromboxane A2.
    Nakayama K; Ueta K; Tanaka Y; Tanabe Y; Ishii K
    Br J Pharmacol; 1997 Sep; 122(2):199-208. PubMed ID: 9313926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
    Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE
    Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.